dbACP: A Comprehensive Database of Anti-Cancer Peptides

dbacp06321

General Description

Peptide name : TP

Source/Organism : Caecum-derived strain TS

Linear/Cyclic : Not found

Chirality : Not found

Sequence Information

Sequence : ASVVNKLTGGVAGLLK

Peptide length: 16

C-terminal modification: Not found

N-terminal modification : Free

Non-natural peptide information: None

Activity Information

Assay type : MTT assay

Assay time : 48h

Activity : IC 50: 11.479 μM

Cell line : NB4

Cancer type : Acute promyelocytic leukaemia

Other activity : Not found

Physicochemical Properties

Amino acid composition bar chart :

Molecular mass : 1526.8192 Dalton

Aliphatic index : 1.4

Instability index : 15.9687

Hydrophobicity (GRAVY) : 0.85

Isoelectric point : 10.003

Charge (pH 7) : 1.7939

Aromaticity : 0

Molar extinction coefficient (cysteine, cystine): (0, 0)

Hydrophobic/hydrophilic ratio : 2.2

hydrophobic moment : -0.072

Missing amino acid : C,R,W,H,Q,P,M,I,E,F,D,Y

Most occurring amino acid : V

Most occurring amino acid frequency : 3

Least occurring amino acid : S

Least occurring amino acid frequency : 1

Structural Information

3D structure :

Secondary structure fraction (Helix, Turn, Sheet): (0.4, 0.3, 0.4)

SMILES Notation: CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O

Secondary Structure :

Method Prediction
GOR HEEEEEEETCEEEEEH
Chou-Fasman (CF) EEECCEEEEEECCCCC
Neural Network (NN) HHHHHCCCCCHHHHHH
Joint/Consensus CEECCEEECCCCCCCC

Molecular Descriptors and ADMET Properties

Molecular Descriptors: Click here to download

ADMET Properties: Click here to download

Cross Referencing databases

Pubmed Id : 28254375

Uniprot : Not available

PDB : Not available

CancerPPD : Not available

ApIAPDB : Not available

CancerPPD2 ID : Not available

Reference

1 : Xin H, et al. Isolation and characterisation of a novel antibacterial peptide from a native swine intestinal tract-derived bacterium. Int J Antimicrob Agents. 2017; 49:427-436. doi: 10.1016/j.ijantimicag.2016.12.012

Literature

Paper title : Isolation and characterisation of a novel antibacterial peptide from a native swine intestinal tract-derived bacterium.

Doi : https://doi.org/10.1016/j.ijantimicag.2016.12.012

Abstract : Antimicrobial peptides (AMPs) are highly associated with antipathogenic activity, without generating drug resistance in targeted bacteria. In this study, the existence of AMPs in the Tibetan swine, a China-native, cold-resistant and seldom-sick breed of pig, was investigated. A peptide secreted by a Tibetan swine intestinal tract-derived Bacillus strain was isolated using reversed-phase chromatography (RPC), ultrafiltration and reversed-phase high-performance liquid chromatography (RP-HPLC). The peptide was identified by mass spectrometry and was characterised for activity against Escherichia coli and Staphylococcus aureus. The 16-amino acid peptide (ASVVNKLTGGVAGLLK), named TP, had a molecular mass of 1568.919 Da and exhibited inhibitory activity against Gram-positive and Gram-negative bacteria [minimum inhibitory concentrations (MICs) of 2.5-5 µM and 10-20 µM for E. coli and S. aureus, respectively] as well as human MKN-45 and NB4 tumour cell lines [50% inhibitory concentration (IC<sub>50</sub>) = 4.686 µM and 11.479 µM, respectively]. TP also exhibited weak haemolytic activity. Furthermore, TP enhanced cell membrane permeability and K+ outflow, bound with E. coli genomic DNA in vitro and inhibited E. coli growth. Thus, TP represents a strong candidate as an antibacterial peptide.